Ultralife Corporation files for late submission of its Q3 2025 results due to system transition after acquiring Electrochem Solutions.
Quiver AI Summary
Ultralife Corporation announced it has filed a Form 12b-25 with the SEC, indicating a delay in submitting its Form 10-Q for the third quarter ended September 30, 2025. The delay is attributed to the recent transition of Electrochem Solutions, Inc., which Ultralife acquired on October 31, 2024, from Integer Holdings Corporation to Ultralife's systems. This transition concluded a services agreement with Integer, requiring Ultralife additional time to finalize financial results and complete the independent review without incurring unreasonable effort or expense. The company expects to file its Form 10-Q by November 17, 2025. Ultralife Corporation, headquartered in Newark, New York, provides a range of products and services including power solutions and communication systems for various markets globally.
Potential Positives
- Ultralife Corporation successfully transitioned Electrochem Solutions, Inc. to its systems following the completion of the acquisition, indicating a significant step in integrating the new business.
- The company is utilizing Form 12b-25, demonstrating compliance with SEC regulations while allowing for thorough financial review, which can enhance transparency and reliability in reporting.
- Ultralife has a clear timeline for filing its Form 10-Q, indicating organizational planning and commitment to timely reporting, which can boost investor confidence.
- Ultralife's diverse business segments in battery & energy products and communications systems position the company well in various markets, potentially driving future growth opportunities.
Potential Negatives
- The company has filed a Notification of Late Filing, which may indicate operational challenges and could raise concerns among investors regarding financial management.
- The delay in finalizing third quarter results could lead to uncertainty about the company's financial health and performance, potentially affecting investor confidence.
- The transition of Electrochem Solutions, Inc. to Ultralife's systems may suggest integration issues that could impact overall company efficiency and effectiveness.
FAQ
What is Ultralife Corporation's recent filing with the SEC?
Ultralife Corporation filed a Form 12b-25, Notification of Late Filing, regarding its Form 10-Q for Q3 2025.
When does Ultralife expect to file its Form 10-Q?
The company anticipates filing its Form 10-Q with the SEC by November 17, 2025.
Why is there a delay in Ultralife's financial reporting?
The delay is due to the transition of Electrochem to Ultralife’s systems, requiring additional time for finalizing results.
What does Ultralife Corporation do?
Ultralife Corporation provides power solutions and communication systems for government, defense, and commercial markets worldwide.
Where is Ultralife Corporation headquartered?
Ultralife Corporation is headquartered in Newark, New York, with operations in North America, Europe, and Asia.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ULBI Insider Trading Activity
$ULBI insiders have traded $ULBI stock on the open market 12 times in the past 6 months. Of those trades, 12 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $ULBI stock by insiders over the last 6 months:
- BRADFORD T WHITMORE has made 8 purchases buying 107,804 shares for an estimated $676,745 and 0 sales.
- THOMAS LOUIS SAELI purchased 5,000 shares for an estimated $27,200
- W. SHAW ROBERT purchased 4,000 shares for an estimated $21,960
- MICHAEL EDWARD MANNA (President and CEO) purchased 3,000 shares for an estimated $15,870
- JANIE GODDARD purchased 1,548 shares for an estimated $11,888
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ULBI Hedge Fund Activity
We have seen 24 institutional investors add shares of $ULBI stock to their portfolio, and 47 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 493,471 shares (-77.2%) from their portfolio in Q2 2025, for an estimated $4,431,369
- PERRITT CAPITAL MANAGEMENT INC added 329,200 shares (+1097.3%) to their portfolio in Q2 2025, for an estimated $2,956,216
- ESSEX INVESTMENT MANAGEMENT CO LLC removed 238,877 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $1,629,141
- RBF CAPITAL, LLC added 225,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $2,020,500
- GEODE CAPITAL MANAGEMENT, LLC removed 125,564 shares (-52.6%) from their portfolio in Q2 2025, for an estimated $1,127,564
- STATE STREET CORP removed 88,971 shares (-70.3%) from their portfolio in Q2 2025, for an estimated $798,959
- ACADIAN ASSET MANAGEMENT LLC removed 86,998 shares (-50.3%) from their portfolio in Q2 2025, for an estimated $781,242
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025.
As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the third quarter of 2025, the transition services agreement between Ultralife and Integer under which Integer maintained the books and records of Electrochem on its information systems concluded, and Electrochem transitioned to Ultralife’s systems. In connection with this transition, Ultralife requires additional time to finalize its third quarter results and to provide sufficient time for completion of the review of our third quarter results by our independent accountants without unreasonable effort or expense. Ultralife expects to file its Form 10-Q with the Securities and Exchange Commission by November 17, 2025, in accordance with Rule 12b-25.
About Ultralife Corporation
Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the Company's business segments include: Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorporation.com .
| Company Contact: | Investor Relations Contact: |
| Ultralife Corporation | Alliance Advisors IR |
| Philip A. Fain | Jody Burfening/Alex Villalta |
| (315) 210-6110 | (212) 838-3777 |
| [email protected] | [email protected] |
| [email protected] |
